EpiBiome
EpiBiome is a microbiome precision engineering biotechnology company that employs a genomics approach to develop therapies to control and treat microbial infections..
Launch date
Market cap
-
Enterprise valuation
€22—33m (Dealroom.co estimates Feb 2016.)
South San Francisco California (HQ)
Financials
Estimates*
| USD | 2018 | 2019 |
|---|---|---|
| Revenues | 3.3m | 4.3m |
| % growth | - | 30 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $100k | Convertible | |
$6.0m | Series A | ||
$1.0m | Debt | ||
| N/A | N/A | Early VC | |
| Total Funding | €5.5m | ||
Recent News about EpiBiome
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.